During the past decade, Sarajishvili Institute of Neurology conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Sarajishvili Institute of Neurology" are "Multiple Sclerosis" (2 trials), "Neuropsychiatric Symptoms Related to Neurodegenerative Disease" (2 trials) and "Relapsing Multiple Sclerosis" (2 trials). Many other conditions were trialed in "Sarajishvili Institute of Neurology" in a lesser frequency.

Most popular intervention types in "Sarajishvili Institute of Neurology" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Ozanimod" (3 trials), "Interferon beta-1a" (2 trials), "Pimavanserin" (2 trials), "Placebo" (2 trials) and "Interferon beta-1a placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sarajishvili Institute of Neurology" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Sarajishvili Institute of Neurology". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Sarajishvili Institute of Neurology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sarajishvili Institute of Neurology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".